<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="utf8">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Risteys – E4_DM2 – detailed case counts by code</title>
		<style type="text/css">
body {
	font-family: sans-serif;
}
.bar-plot-full {
	width: 8rem;
	border-radius: 0.1rem;
	background-color: #f2f2f2;
}
.bar-plot-full div {
	background-color: #c7c7c7;
	height: 1rem;
	border-radius: 0.1rem;
}
		</style>
	</head>
	<body>

		<table>
			<tr>
				<th>Source</th>
				<th>Code</th>
				<th>Name</th>
				<th>Case count</th>
				<th>Share of cases (%)</th>
			</tr>

			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BA02)</td>
					<td>Metformin</td>
					<td>45959</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 84.20483693660682%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E11)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus</td>
					<td>31054</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 56.896299010626606%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E11)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus</td>
					<td>28407</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 52.04653719311103%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>23029</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 42.193111029681205%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>20353</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 37.29021619640894%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>20106</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 36.83766947599854%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>18916</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 34.65738365701722%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH01)</td>
					<td>Sitagliptin</td>
					<td>13321</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 24.406375961890802%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB12)</td>
					<td>Glimepiride</td>
					<td>10110</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 18.523268596555514%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK03)</td>
					<td>Empagliflozin</td>
					<td>6568</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 12.03371198241114%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>5335</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.77464272627336%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>5263</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.642726273360205%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB01)</td>
					<td>Glibenclamide</td>
					<td>5129</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.397215097105168%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD07)</td>
					<td>Metformin and sitagliptin</td>
					<td>5122</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.384389886405277%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E119)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>5004</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.168193477464273%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E119)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>4872</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.926346647123488%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH05)</td>
					<td>Linagliptin</td>
					<td>4750</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.702821546353976%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>4435</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.125687064858923%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>3536</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.478563576401612%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX01)</td>
					<td>Guar gum</td>
					<td>3532</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.4712348845731045%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>3435</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.293514107731769%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK01)</td>
					<td>Dapagliflozin</td>
					<td>3414</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.255038475632099%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>2973</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.447050201539025%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E11)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus</td>
					<td>2969</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.439721509710517%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>2844</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.210699890069622%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E11)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus</td>
					<td>2764</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.06412605349945%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BG03)</td>
					<td>Pioglitazone</td>
					<td>2683</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.915720043972151%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>2478</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.540124587761085%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ02)</td>
					<td>Liraglutide</td>
					<td>2419</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.432026383290583%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>2393</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.384389886405277%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2500A)</td>
					<td>Diabetes mellitus without mention of complication</td>
					<td>2365</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.333089043605717%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH02)</td>
					<td>Vildagliptin</td>
					<td>2100</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.847563209967021%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E11)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus</td>
					<td>1923</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.523268596555515%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>1870</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.4261634298277754%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>1850</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.3895199706852326%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1832</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.356540857456944%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>1675</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.068889703187981%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus</td>
					<td>1628</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.9827775742030047%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1614</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.9571271528032246%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD03)</td>
					<td>Metformin and rosiglitazone</td>
					<td>1510</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.766581165262001%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BG02)</td>
					<td>Rosiglitazone</td>
					<td>1468</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.68962990106266%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>1424</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.6090142909490655%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB07)</td>
					<td>Glipizide</td>
					<td>1384</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.5357273726639793%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX07)</td>
					<td>Liraglutide</td>
					<td>1359</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.4899230487358004%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>1270</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.326859655551484%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>1232</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.257237083180652%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>1228</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.2499083913521436%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus</td>
					<td>1166</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.13631366801026%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX02)</td>
					<td>Repaglinide</td>
					<td>1137</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.083180652253573%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX04)</td>
					<td>Exenatide</td>
					<td>1087</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.991572004397215%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E11)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus</td>
					<td>983</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.8010260168559913%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>938</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.7185782337852693%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E11)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus</td>
					<td>891</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6324661048002933%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX09)</td>
					<td>Dapagliflozin</td>
					<td>889</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6288017588860388%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>874</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6013191645291316%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ01)</td>
					<td>Exenatide</td>
					<td>840</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5390252839868084%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ06)</td>
					<td>Name not found</td>
					<td>829</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5188713814584096%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>785</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.438255771344815%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD08)</td>
					<td>Metformin and vildagliptin</td>
					<td>769</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.4089410040307806%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>704</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.2898497618175155%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E119)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>636</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1652620007328691%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>623</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.141443752290216%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>603</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1048002931476733%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E118)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>597</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.09380725540491%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E118)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>588</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.077317698790766%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ05)</td>
					<td>Dulaglutide</td>
					<td>559</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0241846830340784%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD20)</td>
					<td>Metformin and empagliflozin</td>
					<td>537</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.983876877977281%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>509</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9325760351777207%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E119)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>501</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9179186515207036%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD15)</td>
					<td>Metformin and dapagliflozin</td>
					<td>438</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8024917552216929%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD05)</td>
					<td>Metformin and pioglitazone</td>
					<td>428</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7841700256504214%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>425</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7786735067790399%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E11)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus</td>
					<td>377</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6907292048369367%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(310)_ICD10(E11)</td>
					<td>Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus</td>
					<td>362</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6632466104800293%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>360</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.659582264565775%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>324</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.5936240381091975%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>268</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.4910223525100769%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>261</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.47819714181018685%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E119)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>253</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.4635397581531696%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD11)</td>
					<td>Metformin and linagliptin</td>
					<td>243</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.44521802858189813%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2507A)</td>
					<td>Diabetes mellitus, Diabetes with peripheral circulatory disorders</td>
					<td>224</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.41040674239648217%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1101)</td>
					<td>Non-insulin dependent diabetes diabetic coma with hyperglycaemia</td>
					<td>205</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3755954562110663%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E119)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>189</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3462806888970319%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH03)</td>
					<td>Saxagliptin</td>
					<td>171</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3133015756687431%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2505A)</td>
					<td>Diabetes mellitus, Diabetes with ophthalmic manifestations</td>
					<td>163</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.29864419201172593%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>132</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2418468303407842%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX12)</td>
					<td>Empagliflozin</td>
					<td>120</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.21986075485525836%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E117)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>104</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1905459875412239%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>100</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.18321729571271528%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E119)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>89</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1630633931843166%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E117)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>87</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1593990472700623%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E112)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>74</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1355807988274093%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E118)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>74</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1355807988274093%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>73</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13374862587028213%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2500A)</td>
					<td>Diabetes mellitus without mention of complication</td>
					<td>73</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13374862587028213%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1101)</td>
					<td>Non-insulin dependent diabetes diabetic coma with hyperglycaemia</td>
					<td>73</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13374862587028213%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E112)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>72</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.131916452913155%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E118)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>70</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1282521069989007%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E117)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>68</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.12458776108464639%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2503A)</td>
					<td>Diabetes mellitus, Diabetes with other coma</td>
					<td>67</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.12275558812751923%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2506A)</td>
					<td>Diabetes mellitus, Diabetes with neurological manifestations</td>
					<td>62</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11359472334188349%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD9(E11)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>62</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11359472334188349%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E114)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>59</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10809820447050202%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E112)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>58</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10626603151337487%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2504A)</td>
					<td>Diabetes mellitus, Diabetes with renal manifestations</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1044338585562477%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E114)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1044338585562477%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E112)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1044338585562477%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E116)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>56</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10260168559912054%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E119)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>56</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10260168559912054%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX03)</td>
					<td>Nateglinide</td>
					<td>55</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10076951264199341%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E117)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>54</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09893733968486625%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E116)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>53</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0971051667277391%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD19)</td>
					<td>Linagliptin and empagliflozin</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH04)</td>
					<td>Alogliptin</td>
					<td>48</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08794430194210333%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>47</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08611212898497618%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2508A)</td>
					<td>Diabetes mellitus, Diabetes with other specified manifestations</td>
					<td>41</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07511909124221326%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD10)</td>
					<td>Metformin and saxagliptin</td>
					<td>38</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0696225723708318%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E113)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>38</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0696225723708318%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E113)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>38</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0696225723708318%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E110)</td>
					<td>Name not found</td>
					<td>37</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06779039941370466%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E117)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>36</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0659582264565775%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E117)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>36</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0659582264565775%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>34</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.062293880542323196%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E113)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>33</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06046170758519605%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2501A)</td>
					<td>Diabetes mellitus, Diabetes with ketoacidosis</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05862953462806889%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK02)</td>
					<td>Kanagliflozin</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05862953462806889%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E110)</td>
					<td>Name not found</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.056797361670941744%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E110)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.056797361670941744%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E113)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.056797361670941744%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E112)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>27</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04946866984243312%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E110)</td>
					<td>Diabetes, non-insulin-treated, Name not found</td>
					<td>27</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04946866984243312%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2507A)</td>
					<td>Diabetes mellitus, Diabetes with peripheral circulatory disorders</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.047636496885305975%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E114)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.047636496885305975%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E112)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>24</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.043972150971051664%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E114)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>24</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.043972150971051664%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E118)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>22</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04030780505679736%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03664345914254306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03664345914254306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E111)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03664345914254306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E118)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03664345914254306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>17</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.031146940271161598%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E111)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>17</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.031146940271161598%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD09)</td>
					<td>Pioglitazone and alogliptin</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.027482594356907294%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E113)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.027482594356907294%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E112)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.027482594356907294%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD13)</td>
					<td>Metformin and alogliptin</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.025650421399780136%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ03)</td>
					<td>Lixisenatide</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.025650421399780136%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E116)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.025650421399780136%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E117)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>13</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.023818248442652987%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK04)</td>
					<td>Name not found</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.021986075485525832%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E114)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.021986075485525832%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD21)</td>
					<td>Saxagliptin and dapagliflozin</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02015390252839868%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E115)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02015390252839868%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E113)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02015390252839868%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E116)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01832172957127153%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E114)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.016489556614144377%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E115)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.016489556614144377%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(310)_ICD10(E119)</td>
					<td>Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.016489556614144377%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX10)</td>
					<td>Lixisenatid</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.014657383657017223%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E118)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.014657383657017223%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB02)</td>
					<td>Chlorpropamide</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.012825210699890068%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E113)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.012825210699890068%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E116)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010993037742762916%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2505A)</td>
					<td>Diabetes mellitus, Diabetes with ophthalmic manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2506A)</td>
					<td>Diabetes mellitus, Diabetes with neurological manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2508A)</td>
					<td>Diabetes mellitus, Diabetes with other specified manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2502A)</td>
					<td>Diabetes mellitus, Diabetes with hyperosmolarity</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD8(E11)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E115)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E118)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.009160864785635764%"></div>
						</div>
						
					</td>
				</tr>
			

		</table>

	</body>
</html>
